Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 28, 2023
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
[ Tue, Feb 28th 2023
] - WOPRAI
Mon, February 27, 2023
[ Mon, Feb 27th 2023
] - WOPRAI
[ Mon, Feb 27th 2023
] - WOPRAI
[ Mon, Feb 27th 2023
] - WOPRAI
[ Mon, Feb 27th 2023
] - WOPRAI
Li Watsek Reiterated (BCYC) at Buy and Held Target at $74 on, Feb 27th, 2023
Li Watsek of Cantor Fitzgerald, Reiterated "Bicycle Therapeutics plc" (BCYC) at Buy and Held Target at $74 on, Feb 27th, 2023.
Li has made no other calls on BCYC in the last 4 months.
There are 4 other peers that have a rating on BCYC. Out of the 4 peers that are also analyzing BCYC, 0 agree with Li's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Li
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $72 on, Wednesday, February 15th, 2023
- Swayampakula Ramakanth of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $57 on, Wednesday, February 15th, 2023
- Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $55 on, Wednesday, February 15th, 2023
- Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $46 on, Wednesday, November 9th, 2022
